Nighttime delivery may be risk factor for poor outcome

Article

Newborns who sustain injuries resulting in death are more than twice as likely as controls to have been born at night. To reach that conclusion, Adam C. Urato, MD, of the University of South Florida/Tampa General Hospital in Tampa, Fla., and colleagues looked at times of birth in 80 death cases from the Birth-Related Neurologic Injury Compensation Association database and in a randomly selected group of 1,000 controls.

Newborns who sustain injuries resulting in death are more than twice as likely as controls to have been born at night. To reach that conclusion, Adam C. Urato, MD, of the University of South Florida/Tampa General Hospital in Tampa, Fla., and colleagues looked at times of birth in 80 death cases from the Birth-Related Neurologic Injury Compensation Association database and in a randomly selected group of 1,000 controls.

The researchers found that 36 (45%) of the cases were born between 11 PM and 8 AM compared to 281 (28.1%) of controls. They calculated an odds ratio of 2.09 for the association of nighttime birth with fetal injury resulting in death.

"The implications of our findings are significant," the authors write. "If future research confirms our findings and more fully elucidates the factors underlying the association between nighttime delivery and poor outcome, then changes will have to take place in the areas identified. However, while further research in this area is certainly needed, it is important to note, as other authors have, that other industries have not waited for absolute proof of increased risk at night before initiating changes and establishing regulations."

Recent Videos
HPV self-collection: Benefits, limitations, and future implications | Image Credit: forhers.com
Improving pediatric HPV vaccination rates: Early initiation and addressing disparities | Image Credit: blog.nemours.org.
New cervical cancer screening guidelines: What practitioners needs to know | Image Credit: forhers.com
COVID-19 Therapy Roundtable: Focusing on inpatient care
COVID-19 Therapy Roundtable: Defining the virus today and treatment options
How fezolinetant advances non-hormonal treatment of hot flashes | Image Credit: medschool.cuanschutz.edu
Contraceptive access challenges for college students in contraception deserts | Image Credit: linkedin.com.
Kameelah Phillips, MD, FACOG, NCMP, is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.